Altamidė, MB - financials and debts

Company age: 3 y. 9 mo.

Update

Altamidė - Company finances

EUR
2022
From: 2022-12-16
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 0 0 19,113 32,407
Profit before tax 0 0 10,076 8,775
Net profit 0 0 9,572 8,248
Equity 250 300 9,822 18,070
Liabilities 0 0 874 10,741
Non-current assets 0 0 0 0
Current assets 250 300 10,696 28,811
Total assets 250 300 10,696 28,811
Taxes paid
STI taxes - - 115 504
Financial indicators
Revenue change y/y - - - +69.6%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 0.0% 0.0% 89.5% 28.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 0.0% 0.0% 97.5% 45.6%
Profit margin Net profit margin. Shows the overall profitability of the company. - - 50.1% 25.5%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - 52.7% 27.1%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - 0.1 0.6
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Altamidė - Social security debts

The company had no debts to Sodra

Altamidė - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Altamide, MB (company code 306197842) is a Small partnership engaged in Medical specialists activities. In 2025, the company generated revenue of €32.4K, up 69.5% from €19.1K in 2024. Net profit was €8.2K, compared with €9.6K in the prior year, while the net profit margin declined from 50.1% to 25.5%. This indicates that turnover expanded materially, but profitability eased as costs or other operating items increased faster than sales. Over the two-year period shown, the business moved from a smaller but very high-margin base in 2024 to a larger revenue base in 2025 with still solid earnings. At the end of 2025, total assets amounted to €28.8K, equity to €18.1K and liabilities to €10.7K. The equity ratio was 62.7% and debt-to-equity stood at 0.59, suggesting a moderate leverage position. Return on equity was 45.6%, return on assets 28.6%, and asset turnover 1.12x, reflecting efficient use of assets in 2025.